Areewan Somwangprasert
Chiang Mai University(TH)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Chemotherapy-induced cardiotoxicity and mitigation, Breast Lesions and Carcinomas
Most-Cited Works
- → Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study(2024)54 cited
- → Effects of metformin and donepezil on the prevention of doxorubicin-induced cardiotoxicity in breast cancer: a randomized controlled trial(2023)30 cited
- → Reliability and validity of the Thai translation (Thai PPS Adult Suandok) of the Palliative Performance Scale (PPSv2)(2011)24 cited
- → Intracystic papillary carcinoma of the breast(2005)15 cited
- → Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: a study in HER2-positive and HER2-negative breast cancer patients(2024)15 cited
- → Stage-Specific Survival Rate of Breast Cancer Patients in Northern Thailand in Accordance with Two Different Staging Systems(2019)14 cited
- Breast lymphoscintigraphy for sentinel node identification in breast cancers with clinically-negative axillary nodes.(2005)
- → Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer(2018)8 cited
- Gemcitabine plus cisplatin (GC): a salvage regimen for advanced breast cancer patients who have failed anthracycline and/or taxane therapy.(2006)
- → The association between Ki-67 expression and survival in breast cancer subtypes: a cross-sectional study of Ki-67 cut-point in northern Thailand(2025)6 cited